Neovacs S.A. (ALNEV) — Working Capital to Net Assets Ratio
Neovacs S.A. (ALNEV) has a Working Capital to Net Assets ratio of -2.8% as of December 2025. Working capital of €-512.68K (current assets of €2.64 Million minus current liabilities of €3.15 Million) is measured against net assets of €18.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ALNEV FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Neovacs S.A. Working Capital to Net Assets (2007–2025)
This chart shows how Neovacs S.A.'s Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of December 2025, the ratio stands at -2.8%, reflecting working capital of €-512.68K against net assets of €18.03 Million EUR. See defensive interval ratio of Neovacs S.A. to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Neovacs S.A. (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Neovacs S.A. from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Neovacs S.A. (ALNEV) total market value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -2.8% | €-512.68K | €18.03 Million | €2.64 Million | €3.15 Million | ▲ +5.4 pp |
| 2024 | -8.3% | €-1.50 Million | €18.06 Million | €2.51 Million | €4.00 Million | ▼ -8.5 pp |
| 2023 | 0.2% | €99.64K | €43.82 Million | €3.81 Million | €3.71 Million | ▼ -8.9 pp |
| 2022 | 9.1% | €4.05 Million | €44.23 Million | €9.10 Million | €5.05 Million | ▼ -59.5 pp |
| 2021 | 68.7% | €30.15 Million | €43.90 Million | €34.78 Million | €4.62 Million | ▼ -28.5 pp |
| 2020 | 97.2% | €10.68 Million | €10.98 Million | €13.10 Million | €2.42 Million | ▲ +6.3 pp |
| 2019 | 90.9% | €2.49 Million | €2.74 Million | €7.22 Million | €4.73 Million | ▲ +21.3 pp |
| 2018 | 69.7% | €1.70 Million | €2.44 Million | €6.43 Million | €4.73 Million | ▼ -11.2 pp |
| 2017 | 80.9% | €683.91K | €845.75K | €10.55 Million | €9.87 Million | ▼ -45.8 pp |
| 2016 | 126.6% | €1.59 Million | €1.26 Million | €8.59 Million | €7.00 Million | ▲ +16.6 pp |
| 2015 | 110.0% | €6.67 Million | €6.07 Million | €10.86 Million | €4.19 Million | ▼ -11.9 pp |
| 2014 | 121.9% | €6.79 Million | €5.57 Million | €8.80 Million | €2.01 Million | ▼ -5.4 pp |
| 2013 | 127.3% | €4.43 Million | €3.48 Million | €7.33 Million | €2.91 Million | ▲ +4.8 pp |
| 2012 | 122.5% | €4.43 Million | €3.62 Million | €5.87 Million | €1.44 Million | ▲ +16.4 pp |
| 2011 | 106.1% | €11.21 Million | €10.57 Million | €12.61 Million | €1.40 Million | ▼ -1.1 pp |
| 2010 | 107.2% | €8.87 Million | €8.27 Million | €10.40 Million | €1.53 Million | ▲ +103.9 pp |
| 2009 | 3.2% | €-11.41K | €-352.58K | €4.27 Million | €4.28 Million | ▼ -103.2 pp |
| 2008 | 106.5% | €6.93 Million | €6.51 Million | €8.36 Million | €1.42 Million | ▼ -19.8 pp |
| 2007 | 126.3% | €2.49 Million | €1.97 Million | €3.64 Million | €1.15 Million | — |